Daniel L. Flynn Ph.D.
Net Worth

Last updated:

What is Daniel L. Flynn Ph.D. net worth?

The estimated net worth of Dr. Daniel L. Flynn Ph.D. is at least $22,820,507 as of 16 Jun 2023. He has earned $17,040,427 from insider trading and has received compensation worth at least $5,780,080 in Deciphera Pharmaceuticals, Inc..

What is the salary of Daniel L. Flynn Ph.D.?

Dr. Daniel L. Flynn Ph.D. salary is $722,510 per year as Executive Vice President, Chief Scientific Officer & Founder in Deciphera Pharmaceuticals, Inc..

How old is Daniel L. Flynn Ph.D.?

Dr. Daniel L. Flynn Ph.D. is 70 years old, born in 1955.

What stocks does Daniel L. Flynn Ph.D. currently own?

As insider, Dr. Daniel L. Flynn Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Deciphera Pharmaceuticals, Inc. (DCPH) Executive Vice President, Chief Scientific Officer & Founder 57,158 $0 $0

What does Deciphera Pharmaceuticals, Inc. do?

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.

DCPH logo
DCPH
Deciphera Pharmaceuticals, Inc.

Daniel L. Flynn Ph.D. insider trading

Deciphera Pharmaceuticals, Inc.

Dr. Daniel L. Flynn Ph.D. has made 15 insider trades between 2017-2023, according to the Form 4 filled with the SEC. Most recently he sold 1,655 units of DCPH stock worth $23,835 on 16 Jun 2023.

The largest trade he's ever made was exercising 1,066,530 units of DCPH stock on 2 Oct 2017. As of 16 Jun 2023 he still owns at least 57,158 units of DCPH stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 1,655 $14.4 $23,835
Sale
Common Stock 1,370 $15.1 $20,686
Sale
Common Stock 2,403 $21.24 $51,042
Sale
Common Stock 1,768 $10.75 $19,006
Sale
Common Stock 1,366 $9.05 $12,362
Sale
Common Stock 508 $48.87 $24,826
Option
Stock Option (Right to Buy) 9,029 $1.89 $17,065
Option
Common Stock 9,029 $1.89 $17,065
Option
Stock Option (Right to Buy) 130,000 $1.89 $245,700
Option
Common Stock 130,000 $1.89 $245,700
Option
Common Stock 66,906 $5.04 $337,206
Option
Stock Option (Right to Buy) 77,012 $4.68 $360,185
Sale
Common Stock 31,029 $60 $1,861,740
Option
Stock Option (Right to Buy) 122,752 $55 $6,751,360
Sale
Common Stock 28,822 $55 $1,585,210
Option
Common Stock 122,752 $55 $6,751,360
Option
Stock Option (Right to Buy) 30,175 $1.89 $57,031
Option
Common Stock 30,175 $1.89 $57,031
Sale
Common Stock 30,175 $1.89 $57,031
Option
Stock Option (Right to Buy) 143,185 $48.01 $6,874,885
Option
Common Stock 143,185 $48.01 $6,874,885
Sale
Common Stock 143,185 $48.01 $6,874,885
Sale
Common Stock 9,742 $1.89 $18,412
Option
Common Stock 9,742 $1.89 $18,412
Option
Stock Option (Right to Buy) 9,742 $1.89 $18,412
Option
Stock Option (Right to Buy) 29,820 $1.89 $56,360
Sale
Common Stock 29,820 $1.89 $56,360
Option
Common Stock 29,820 $1.89 $56,360
Option
Stock Option (Right to Buy) 123,107 $1.89 $232,672
Sale
Common Stock 148,107 $41.5 $6,145,996
Option
Common Stock 123,107 $1.89 $232,672
Option
Stock Option (Right to Buy) 24,500 $3.95 $96,775
Option
Common Stock 24,500 $3.95 $96,775
Sale
Common Stock 152,629 $1.89 $288,469
Option
Stock Option (Right to Buy) 152,629 $1.89 $288,469
Option
Common Stock 152,629 $1.89 $288,469
Option
Stock Option (Right to Buy) 300 $1.89 $567
Option
Common Stock 300 $1.89 $567
Sale
Common Stock 300 $1.89 $567
Option
Stock Option (Right to Buy) 110,727 N/A N/A
Option
Stock Option (Right to Buy) 1,066,530 N/A N/A

Deciphera Pharmaceuticals key executives

Deciphera Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: